Robb Gary Charles

US insider· US
Sign in for alerts
  • ACQUIREDT+30

    Corcept Therapeutics Inc · NASDAQ

    +5,000 sh

    Filed 28 Sept 2026SEC Form 4view source
  • REDUCEDT+30

    Corcept Therapeutics Inc · NASDAQ

    −17,100 sh

    Filed 28 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    Corcept Therapeutics Inc · NASDAQ

    +5,000 sh

    Filed 28 Sept 2026SEC Form 4view source
  • ACQUIREDT+30

    Corcept Therapeutics Inc · NASDAQ

    +17,493 sh · $144.7K

    Filed 18 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Corcept Therapeutics Inc · NASDAQ

    +164 sh · $18.6K

    Filed 3 Sept 2026SEC Form 4view source
  • REDUCEDStale

    Corcept Therapeutics Inc · NASDAQ

    −91 sh · $10.3K

    Filed 3 Sept 2026SEC Form 4view source
  • ACQUIREDStale

    Corcept Therapeutics Inc · NASDAQ

    +164 sh

    Filed 3 Sept 2026SEC Form 4view source